Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Medtronic Temporarily Modifies Several Cardiopulmonary Product Indications for Longer Duration Use in ECMO Therapy to Address COVID-19

During this critical time, Medtronic remains committed to our strategy of delivering critical care products designed and indicated for Extracorporeal Membrane Oxygenation (ECMO) to treat patients around the world. Following guidance issued by the U.S. FDA on April 6, 2020, several Medtronic cardiopulmonary technologies are now permitted to temporarily be used in the U.S. for ECMO therapy greater than six hours.

Under this new guidance the FDA is allowing temporary limited modifications to the indications of certain FDA-cleared or FDA-approved cardiopulmonary devices without prior submission of premarket notification. These modifications are allowed, considering the public health emergency, when they do not create an undue risk. This limited indication modification for ECMO therapy greater than six hours has not been cleared or approved by the FDA and is in effect only for the duration of the public health emergency related to COVID-19 as declared by the Department of Health and Human Services (HHS).

The devices listed below are currently FDA-cleared for extracorporeal support for periods appropriate to cardiopulmonary bypass procedures (up to 6 hours).

In accordance with the new FDA guidance, the devices listed below can now be used for longer than 6 hours in an ECMO circuit to treat patients who are experiencing acute respiratory/cardiopulmonary failure during the COVID-19 Public Health Emergency*.

  • Bio-Console™ 560 Extracorporeal Blood Pumping Console with Accessories
  • Autoclamp
  • Bubble Detector (adult)
  • Bubble Detector (pediatric)
  • External Drive Motor for Affinity™ CP Centrifugal Blood Pump
    Emergency Hand Crank for Affinity™ CP Centrifugal Blood Pump
  • TX50 Adult Flow Transduce
  • Adult Bio-Probe™ Flow Probe
  • Adult Bio-Pump Flow Probe™ with Cortiva™ BioActive Surface
  • Adult Bio-Pump Flow™ Probe with Trillium Biosurface
  • TX50P Pediatric Flow Transducer
  • Pediatric Bio-Probe™ Flow Probe
  • Pediatric Bio-Probe™ Flow Probe with Cortiva™ BioActive Surface
  • Pediatric Bio-Pump™ Flow Probe with Trillium Biosurface
  • Affinity™ CP Adapter
  • Affinity™ Centrifugal Blood Pumps:
  • Affinity™ CP Centrifugal Blood Pump
  • Affinity™ CP Centrifugal Blood Pump with Cortiva BioActive Surface
  • Affinity™ CP Centrifugal Blood Pump with Balance Biosurface

The special supplement to the products’ Instructions for Use (IFU) can be found on the Medtronic website for U.S. eManuals. This special supplement contains information on:

  • Available data on design characteristics and use conditions related to ECMO
  • Performance and durability testing summary
  • Potential risks related to the use of the device for ECMO
  • Clinical signs or observations that require device change-out

Extracorporeal membrane oxygenation (ECMO) is a life supporting therapy. People who need ECMO have a severe and life-threatening illness that stops their heart or lungs from working properly. ECMO therapy temporarily replaces the function of the heart and/or lungs by pumping blood from the patient’s body to an oxygenator that provides long term physiological gas exchange (oxygen and carbon-dioxide transfer).

About Medtronic
Medtronic plc, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Why Healthy Students Are Better Learners

Why Healthy Students Are Better Learners

Experts confirm that health and education are directly related. When students are strong and healthy, they can concentrate better in class. Healthy students also tend to have higher attendance records than students who don’t receive proper nutrition.

Even though nutrition is a major contributor toward student health, exercise and other environmental factors also influence student health on several levels. Holistic student health incorporates the physical, social and emotional status of students, making health a complex issue.

Informed health choices

When students are better educated, they can make informed choices to support their health and learning capacities. Exercise, good nutrition and a positive emotional environment are the major factors that support productive learning. When these elements are not in place, students experience stress.

They may fall asleep in classrooms and miss most of the lesson due to poor nutrition, or it may be difficult to focus if they are emotionally stressed. A lack of sleep is another element that impacts the learning experience. To maintain health while studying, students should be able to access basic information on how to look after their wellbeing if they are to perform optimally.

Eat nutritious foods

Fresh fruit and vegetables should be eaten daily as these contain vitamins and minerals necessary for brain development and concentration. Students should ensure they eat enough proteins to support their physical growth, as this is another vital part for growing bodies and minds.

If students suffer from deficiencies due to eating excessive amounts of processed foods and take in insufficient fresh foods, their concentration can be severely impaired. When concentration suffers due to poor eating habits, academic performance will also suffer.

Although there are very good services that offer college term papers and other assignment writing help, especially from EduBirdie, it does not mean students should compromise on health. Taking help from professional writers can be beneficial in many other ways, like when you are stressed, struggling with tight deadlines, etc.

Get sufficient exercise

Student health rests strongly on gaining enough exercise. Fresh air and individual or team sports support cognitive development as much as classroom learning does. Personal abilities are developed, together with the capacity to work with others on a social level.

Discipline is another valuable side-effect of exercise, which serves to strengthen the immune system and enhance focus in the classroom. If students are lethargic or weak due to a lack of exercise, their concentration is negatively impacted. Also, their energy levels won’t be at an optimum to absorb information in the classroom.

Children and teenagers need sleep

Children and teenagers expend enormous amounts of energy when awake, which is partly why they eat and sleep so much. Because these are growing years, their bodies also require large amounts of quality food and sleep.

If they are getting enough sleep, good food and their emotional environment is supportive, they are more likely to perform well with their academic work. The reverse is also true. When these elements are not in place, their academic performance is bound to suffer unnecessarily.

Coordinated school and college policies

Coordinated health plans in schools and colleges are large contributors toward overall student health. Planned education policies recognize that total health is a factor in achieving positive academic outcomes for all students.

Because student health is important, it takes time to develop policies and implement comprehensive action plans to look after their wellbeing outside the family home. Federal plans to promote wellness are complex due to the diverse levels that contribute to overall health but are necessary as healthy students learn better.

Student counselors and academic progress

If a student experiences a problem at home, they can speak to a school counselor to find a solution. Home environments may be negative for emotional health, so students can access school resources to try and manage their wellbeing.

When students’ emotional well-being is negatively impacted, learning becomes more difficult because of the stress they experience. This is why it is important to offer support outside the family home. Parent and teacher communities are often required to monitor students’ emotional circumstances and intervene if necessary.

Conclusion

Healthy students learn better because their physical, emotional and mental wellbeing is balanced. Happy students can focus better, and when their overall health is supported by exercise, good nutrition and a supportive emotional environment, they are less stressed. Stress on any of these levels is bound to impact academic learning, which is why student health needs to be supported and maintained.

About Robert Everett

Robert Everett is an academic writer and editor working with an online assignment service as the lead thesis and dissertation writer. He also provides online classes to students who plan to become professional writers and authors. In his free time, he practices mindfulness, goes out for long walks and listens to pop music.

Siemens Healthineers Receives FDA Emergency Use Authorization for its SARS-CoV-2 Total Antibody Test that Delivers Superior Clinical Performance

Siemens Healthineers Receives FDA Emergency Use Authorization for its SARS-CoV-2 Total Antibody Test that Delivers Superior Clinical Performance

Siemens Healthineers announced the U.S. FDA has issued an Emergency Use Authorization (EUA) for its laboratory-based total antibody test to detect the presence of SARS-CoV-2 antibodies including IgM and IgG in blood. Test data demonstrated 100 percent sensitivity2 and 99.8 percent specificity. The total antibody test allows for identification of patients who have developed an adaptive immune response, which indicates recent infection or prior exposure. Testing can begin immediately with more than one million tests already shipped to health systems and laboratories.

A spike protein on the surface of the SARS-CoV-2 virus enables the virus to penetrate and infect human cells found in multiple organs and blood vessels. The Siemens Healthineers Total Antibody COV2T assay was thoughtfully designed to detect antibodies to the spike protein. These antibodies are believed to neutralize the SARS-CoV-2 virus and therefore prevent infection. Multiple potential vaccines in development for SARS-CoV-2 include the spike protein within their focus.

“As a leader in laboratory diagnostics, Siemens Healthineers designed a high-quality, highly accurate antibody test with the capacity and reach necessary to help address a critical societal need,” said Deepak Nath, PhD, President, Laboratory Diagnostics, Siemens Healthineers. “The test targets both IgM and IgG antibodies, which allows for early identification of individuals infected with the virus who have developed an immune response, even if they were asymptomatic or never diagnosed with the disease.”

About Antibody Test Specificity

Tests with high level of specificity yield low false positive rates, which is highly desirable especially when prevalence of disease is low. For example, a test with 99.8 percent specificity, in populations with low disease prevalence (e.g., 5 percent), will yield a positive predictive value (PPV) of 96.5 percent. In other words, 96.5 people in 100 testing positive will truly have antibodies. This number only goes up as the disease prevalence increases; for example, in communities with 10 percent of disease prevalence, this test would yield a PPV of 98.3 percent, meaning that 98.3 people in 100 people with positive tests results have antibodies. High-quality antibody testing is vital to accurately assess the prevalence of disease, which varies across the U.S.

“As one of the leading specialized laboratories, we recognized the critical need of our customers to have rapid and accurate testing to manage COVID-19 among their patients and staff,” said Paul F. Beyer, CEO of Ascend Clinical. “The Siemens Healthineers total antibody test enables us to confidently deliver fast, reliable results that will be extremely valuable in the surveillance of the disease.”

The total antibody test SARS-CoV-2 Total (COV2T)3 is available on the largest installed base of high-throughput analyzers, including the Atellica® IM immunoassay analyzers, which can run up to 440 tests per hour1 and enables a result in just 10 minutes. The test also is available on the company’s expansive installed base of ADVIA Centaur® XP and XPT analyzers, which can test up to 240 samples per hour with a result in 18 minutes.

Comparable antibody tests4 for Siemens Healthineers Dimension Vista® and Dimension® EXL systems started shipping on May 29, further extending clinical reach across the company’s 20,000 systems installed worldwide.

The tests were developed in the epicenter of the pandemic, are manufactured in Walpole, Mass. and Newark, Del., and are distributed from Plainfield, Indiana. The company is prepared to ramp up production as the pandemic evolves with capacity exceeding 50 million tests per month across its platforms starting in June.

About Siemens Healthineers Commitment to COVID-19 Testing

In addition to antibody and molecular SARS-CoV-2 tests, Siemens Healthineers offers a broad diagnostics portfolio to aid in the prognosis, treatment and follow up of COVID-19 patients. The company’s broad and differentiated menu includes hematology, coagulation, cardiac, respiratory, inflammation and infectious disease panels. Blood gas and imaging solutions from Siemens Healthineers deliver actionable results that aid clinicians in caring for COVID-19 patients.

This project has been funded in whole or in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), Division of Research Innovation and Ventures under Contract No. 75A50120C00111.

About Siemens Healthineers AG
Siemens Healthineers AG is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion.

Kindred Healthcare to Expand Behavioral Health Services with Acquisition of Two Hospitals in Texas

Kindred Healthcare to Expand Behavioral Health Services with Acquisition of Two Hospitals in Texas

Kindred Healthcare, LLC announced it has signed a definitive agreement with WellBridge Healthcare to acquire two behavioral health hospitals, WellBridge Greater Dallas and WellBridge Fort Worth, in the Dallas-Fort Worth metropolitan area.

WellBridge Greater Dallas and WellBridge Fort Worth provide a full continuum of inpatient and outpatient behavioral health services to senior and adult populations in North Texas. Each hospital has 48 licensed beds and both are regional leaders in behavioral healthcare with a history of providing exceptional behavioral health treatment services and superior clinical outcomes. Kindred plans to continue using the WellBridge name.

This acquisition advances Kindred’s objective of expanding the Company’s behavioral health services. Kindred is dedicated to providing hope, healing and recovery for the most medically complex patients – a mission that naturally extends to those suffering from behavioral health issues. Through Kindred Behavioral Health (“KBH”), Kindred is focused on addressing the unmet need for high-quality, specialized and compassionate behavioral health services, including crisis stabilization for acute mental health and substance use disorders; detoxification from alcohol, opiates, cocaine and other drugs; suicidal thoughts or actions, anxiety, depression and post-traumatic stress disorder; and many other behavioral health illnesses.

Under the leadership of Rob Marsh, Senior Vice President and Chief Operating Officer for Behavioral Health, Kindred intends to continue growing its behavioral health footprint across the United States through joint ventures and distinct part unit management with leading hospital systems, in addition to opportunistic acquisitions and organic growth opportunities. Kindred believes that behavioral health services are highly complementary to Kindred’s other facility-based healthcare services and build upon its existing clinical and operational capabilities.

“Kindred is proud to provide specialized, high-quality care for patients who are acutely sick or facing medically complex diagnoses,” said Jason Zachariah, Kindred’s Chief Operating Officer. “Our expansion into behavioral health services is consistent with our mission and is a natural extension of the high-quality services we provide in our long-term acute care hospitals and inpatient rehabilitation facilities. We look forward to applying our expertise and experience to serve more patients with behavioral health issues.”

Mr. Zachariah added, “Kindred has a successful track record of incubating new business lines to address unmet healthcare needs, and this expansion extends that record and advances the Company’s long-term growth objectives. Rob Marsh, along with his seasoned leadership team, bring significant industry and operational expertise, and we are confident KBH is poised for growth and success under their leadership.”

Mr. Marsh said, “Since joining Kindred last year, I have been inspired by the tireless commitment of team members across the Company to supporting our patients and their families. By expanding KBH, Kindred will be able to help more patients reach their highest potential for health and healing. I am thrilled to have an experienced leadership team alongside me at KBH and, supported by the clinical, operational and financial strength of Kindred, I am confident we will successfully expand Kindred’s behavioral healthcare continuum and drive strong revenue growth and patient outcomes.”

The transaction is expected to close in the summer of 2020, subject to the receipt of standard regulatory approvals and customary closing conditions.

About Kindred Healthcare

Kindred Healthcare, LLC is a healthcare services company based in Louisville, Kentucky with annual revenues of approximately $3.2 billion(1). At March 31, 2020, Kindred through its subsidiaries had approximately 31,800 employees providing healthcare services in 1,731 locations in 46 states, including 64 long-term acute care hospitals, 21 inpatient rehabilitation hospitals, 10 sub-acute units, 95 inpatient rehabilitation units (hospital-based) and contract rehabilitation service businesses which served 1,541 non-affiliated sites of service. Ranked as one of Fortune magazine’s Most Admired Healthcare Companies for nine years, Kindred’s mission is to help our patients reach their highest potential for health and healing with intensive medical and rehabilitative care through a compassionate patient experience

Honeywell Launches Solutions to Help Improve Building Health and Reassure Occupants

Honeywell Launches Solutions to Help Improve Building Health and Reassure Occupants

Honeywell launched an integrated set of solutions to help building owners improve the health of their building environments, operate more cleanly and safely, comply with social distancing policies, and help reassure occupants that it is safe to return to the workplace. By integrating air quality, safety and security technologies along with advanced analytics, Honeywell’s Healthy Buildings solutions are designed to help building owners minimize potential risks of contamination and ensure business continuity by monitoring both the building environment and building occupants’ behaviors.

Honeywell’s new solutions provide building owners with more control over critical health, safety and security factors to encourage sustained compliance with changing building standards, safety guidelines, government-issued regulations and a company’s risk management policies. These innovative solutions also provide transparency into a building’s health status to its occupants.

“The COVID-19 pandemic is changing the culture of how buildings are managed by making apparent the need to ensure health and well-being in all aspects of our lives,” said Vimal Kapur, president and CEO of Honeywell Building Technologies. “Honeywell has developed outcome-based solutions that allow building owners to transparently address how they limit exposure to and the spread of viruses while supporting their business continuity needs in an uncertain environment. We’re giving them the data they need to confidently reassure their employees to accelerate their business operations.”

Kapur added: “Returning to work after a pandemic will not be returning to business as usual. Occupants will want credible information and increased visibility into how building technology is protecting their health and what has been done to ensure that the buildings they enter are safe. Healthy buildings go beyond just energy efficiency to ensure the health, comfort, confidence and productivity of the people who use them.”

Honeywell’s Healthy Buildings solutions are part of a comprehensive effort among Honeywell’s businesses to come together to quickly develop solutions that are helping important sectors of the global economy recover. Honeywell’s Healthy Buildings solutions provide a holistic view of a building’s health based on key factors such as indoor air quality, occupant flow, personal protection equipment (PPE) analytics, thermal screening, social distancing and sanitation efficacy.

Honeywell’s novel #HealthyBuildings Score analytics provide real-time alerts to building owners and operators so they can quickly address non-compliance issues or deal with infection-related incidents. The #HealthyBuildings Score comprises key building health metrics that can be provided to occupants in a simplified view on a dashboard. Healthy Buildings outcomes are powered by Honeywell Forge and monitored via the #HealthyBuildings score.

Honeywell’s Healthy Buildings solutions features two packages – one focused on indoor air quality and another on safety and security.

The Honeywell Healthy Buildings Air Quality package monitors, manages and controls key parameters to create a healthier built environment while still managing energy efficiency. The Air Quality package can:

Help building owners implement the latest ASHRAE and other local guidelines;
Manage pressurization, ventilation, temperature and humidity;
Gauge environmental and occupancy parameters;
Provide real-time insights on contaminant risk, alerts to change HEPA filters, cleaning and occupant behavior; and
Control and optimize UV sterilization, air filtration and air composition.

The Honeywell Healthy Buildings Safety & Security package features hardware and software that can help building owners minimize risk by monitoring, detecting and responding to potential issues using integrated security tools. The Safety & Security package can:

Manage people flow and reporting, people counting, proactive property protection, thermal temperature screening and PPE mask detection;
Monitor and help sustain compliance with social distancing, space sanitation; and
Support contact tracing due to potential virus exposure by leveraging advanced video analytics and incident management workflows.

The Honeywell Healthy Buildings solutions can support the needs of any building and features specific solutions for premium commercial buildings, airports, hospitality, healthcare and education sectors. The fully integrated air quality, health, safety and security controls are backed by expert services and remote monitoring support. Customers can also leverage their existing infrastructure, including third-party solutions, to affordably enhance air quality and security outcomes.

Other businesses within Honeywell are introducing innovative new technologies to provide a healthier environment for customers and end users. For example, Honeywell recently announced its ThermoRebellion temperature monitoring solution, which can be rapidly deployed at the entryway of a factory, airport, distribution center, stadium or other commercial buildings to quickly and efficiently identify whether personnel exhibit an elevated facial temperature.

The company has also developed an Environment Control System Health check that allows airlines to quickly use aircraft data and advanced analytics to monitor for and ensure healthy air quality in the cabin. Additionally, it’s applying the Honeywell Forge platform to help customers operate their buildings, factories, warehouses, supply chains, and aircraft more efficiently and in ways that promote the health and safety of occupants, workers, and passengers.

About Honeywell Building Technologies

Honeywell Building Technologies (HBT) is a global business with more than 23,000 employees. HBT creates products, software and technologies found in more than 10 million buildings worldwide. Commercial building owners and occupants use our technologies to ensure their facilities are safe, energy efficient, sustainable and productive.

Honeywell is a Fortune 100 technology company that delivers industry specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable.

Boston Scientific Launches DIRECTSENSE Technology

Boston Scientific Launches DIRECTSENSE Technology

Boston Scientific announced the U.S. launch of the DIRECTSENSE Technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures. Available on the RHYTHMIA HDx™ Mapping System, the DIRECTSENSE Technology, which received U.S. FDA approval in April, is the only tool to monitor changes in local impedance – electrical resistance – around the tip of the INTELLANAV™ MiFi Open-Irrigated (OI) ablation catheter, offering physicians an additional measurement of therapy effect during an ablation.

Ablation is a treatment option for patients with cardiac arrhythmias in which physicians use a catheter to create lesions and destroy heart tissue that causes abnormal rhythms. The DIRECTSENSE Technology provides data on the impedance around the catheter tip to measure the ability of the tissue to respond to RF energy before physicians deliver therapy. During ablation, the tool tracks the change in local impedance which, in conjunction with other measures, offers physicians a distinct understanding of tissue characteristics and how they are affecting that tissue. These insights may indicate temperature change in the tissue, helping to reduce the chances of over-ablation and avoid complications.

“Knowing the change in impedance around the tip of the catheter provides unique information about local tissue characteristics and the development of the lesion,” said David J. Callans, M.D., professor of medicine at the Perelman School of Medicine, University of Pennsylvania – the first center to use the new technology in the U.S. “Unlike existing products on the market, the DIRECTSENSE Technology assists physicians in evaluating pre-ablation tissue health, while supporting better clinical understanding of how they are influencing that tissue to guide minimal, predictable ablation during a procedure.”

According to chronic data from the LOCALIZE clinical trial, a retrospective analysis of the DIRECTSENSE Technology presented by Ignacio Garcia-Bolao, M.D., director of cardiology and cardiovascular surgery, University of Navarra, Pamplona, Spain at Heart Rhythm Society 2020 Science, a local impedance decrease of ≥16.6 ohms with an inter-lesion spacing of ≤ 6mm showed a ≥ 98% positive predicative value of durable pulmonary vein block at three months in patients with paroxysmal atrial fibrillation (AF).

“Building upon the success seen with the DIRECTSENSE Technology in Europe, we are pleased to introduce this tool to physicians and their patients in the U.S.,” said Kenneth Stein, M.D., senior vice president and chief medical officer, Rhythm Management and Global Health Policy, Boston Scientific. “This approval marks an exciting milestone for our growing electrophysiology portfolio, providing physicians a more direct understanding of lesions and procedural efficiency to obtain optimal patient outcomes.”

The company continues to expand its electrophysiology offerings with the recently granted CE Mark for the POLARx™ Cryoablation System and plans to launch the product and begin enrolling European patients in a post-approval registry with the device in the coming months. The addition of this new single-shot therapy, alongside existing products and services, affirms the company’s commitment to providing meaningful advancements for the treatment of patients with AF.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.

HashCash Offers Scalable Virtual Solutions to Healthcare Industry for Post-COVID Reformation

Virtual Solutions to Healthcare Industry for Post-COVID Reformation

HashCash Consultants is working with healthcare establishments, helping them with advanced technology and virtual solutions that can meet the needs of a COVID-riddled world, while shaping a robust healthcare infrastructure fit for the post-pandemic world.

HashCash’s healthcare solutions abide by the necessary compliances and augment the caregiving standards through the establishment of an agile, collaborative, and automated digital infrastructure, that can scale-up to meet futuristic needs as well.

“Although the healthcare industry has been at the frontline in the global battle against COVID-19, the pandemic has exposed some of the fundamental flaws within the system that needs immediate fixing to mitigate any crisis of the pandemic variety in the future. With social distancing becoming the new normal, new strategies and innovative solutions directed towards the digital transformation of the legacy healthcare is the need of the hour”, commented Raj Chowdhury, CEO, HashCash Consultants.

HashCash has risen to the occasion offering comprehensive and customized solutions powered by advanced automation and integration modules that help in bringing significant reformation into the traditional architecture and streamline various processes.

HashCash Consultants’ Solutions for the Healthcare Industry:

All healthcare establishments like hospitals, diagnostic laboratories, pharmacies, clinics, etc. have been working round the clock, to mitigate the pandemic induced crisis. Being open 24×7 to provide medical support to the people, maintaining social distancing becomes a challenge. However, physical interaction can be minimized by digitally transforming existing healthcare systems.

Hospitals:

HashCash helps hospitals to optimize their operations by integrating the legacy system with virtual communication and collaboration tools, to keep human physical interactions to the minimum. Digitized healthcare system by HashCash for hospitals enables:

1. Virtual appointment through intuitive and user-friendly applications
2. Virtual consultation via customized video conferencing platforms so that the doctor can diagnose the patient without the need for the later to visit the hospital physically.
3. All interactions between the doctor and patient, including the exchange of medical reports and prescriptions, takes place over a highly secured platform.
4. AI-powered applications that help in risk assessment by analyzing the symptoms and alerts the patient and the hospital if it is an admission emergency

HashCash helps hospitals to create a bond of trust with the patients by upholding the highest privacy standards with advanced security protocols integrated into the overall system so that the patients feel safe both physically and virtually.

Clinics and Diagnostic Laboratories:

The pandemic has changed the system of general medical practice and the way a clinic or diagnostic lab used to operate before COVID-19. HashCash’s specialized healthcare solutions and services allow physicians to run virtual clinics, where a system integrated application with agile communication tools takes care of everything from getting appointment and payment to virtual consultation. The use of advanced security protocols fortifies the system maintaining absolute privacy of all patient data.

For diagnostic labs, HashCash created applications that allow the patient to register all the tests that need to be done, along with online payment and confirmation. Patients get time slots for tests through the app to avoid crowding. Although the tests need expert supervision, the dispersal of results happens through the virtual platform as well.

Pharmacy:

HashCash helps pharmacies to create its eCommerce platform that enables online ordering and delivery through digitized and automated solutions. Powered by advanced digital technology, the pharma app enables patients to register their prescriptions and place an order for medicines. The integration of a payment processor makes for seamless payment in a few simple steps, while the customer gets notified in every step from placing the order till delivery.

All the mentioned digital healthcare solutions are designed keeping both the present scenario and future context in mind, enabling rapid crisis management and seamless collaboration between people and the organizations.

About HashCash Consultants:

HashCash is a global software company. HashCash Blockchain products enable enterprises to move assets and settle payments across borders in real-time for Remittances, Trade Finance, Payment Processing, and more. HashCash runs US-based digital asset exchange, PayBito & digital asset payment processor, BillBitcoins. HashCash offers exchange and payment processor software solutions, ICO Services, and customized use cases. HashCash propels advancement in technology through Blockchain1o1 programs and its investment arm, Satoshi Angels. HashCash offers solutions in AI, Big Data, and IoT through its platforms, products & services. HashCash solves the toughest challenges by executing innovative digital transformation strategies for clients around the world.

OnCall Health Teams Up With Lumino Health to Connect Healthcare Professionals With Virtual Care Technology

Connect Healthcare Professionals With Virtual Care Technology

OnCall Health announced a commercial partnership with Lumino Health, an innovation from Sun Life, to connect healthcare providers with Canadians from a distance.

OnCall Health is providing its virtual care software to healthcare providers on the Lumino Health network, Canada’s largest network of healthcare providers. OnCall Health’s simple and secure virtual care software is trusted by over 600 healthcare organizations and thousands of primary care, mental health, and paramedical service providers throughout North America. It enables healthcare providers on the Lumino Health network to connect virtually with patients, automate administrative processes such as online scheduling of appointments, and expand their operations by reaching more patients faster.

“Lumino Health shares our vision that virtual care is part of the new normal in healthcare, especially in a post-COVID world,” says Nicholas Chep, founder and CEO of OnCall Health. “With a network of more than 150,000 healthcare providers in Canada, this partnership represents a significant opportunity to make our virtual care technology part of every healthcare provider’s toolkit.”

According to the Canadian Medical Association, 71 per cent of Canadians would like to book appointments electronically. But just nine per cent of family physicians offer this option*. OnCall Health and Lumino Health are making it easy for healthcare providers to incorporate online booking and virtual care into their practices. Healthcare providers can also see more patients faster by automating administrative work like scheduling, appointment reminders, consent forms, and payment processing.

“While Canadians continue to practice physical distancing and go online for their healthcare needs, we know the desire for virtual options is here to stay,” says Chris Denys, Senior Vice-President, Lumino Health, Sun Life. “Our collaboration with OnCall Health will help healthcare providers stay connected to their patients. Now more than ever, this technology will be key to the future of healthcare.”

“We are currently seeing an unprecedented need for virtual care. Our platform provides everything that healthcare providers and networks like Lumino Health need to quickly incorporate this approach to healthcare delivery into their practice, at scale,” adds Chep.

OnCall Health’s premium white label virtual care platform helps healthcare enterprises manage their virtual care operations at scale through secure video, instant messaging, digital forms and assessments, and analytics on any device or web browser.

Healthcare organizations can customize the OnCall Health platform with their own branding to provide a consistent and professional experience for patients. An analytics dashboard lets healthcare providers measure key metrics for virtual care programs – such as usage, appointment attendance, clinical outcomes – and patient satisfaction surveys. It also meets PHIPA and PIPEDA patient privacy compliance standards, and 256-bit E2E encryption. All data is hosted on Canadian servers.

About OnCall Health

Founded in 2016, OnCall Health is the Canadian market leader in simple, secure virtual care, powering over one million virtual healthcare appointments each year. Thousands of healthcare providers trust OnCall Health to expand and improve access to their services. OnCall Health’s virtual care platform enhances the patient experience, protects privacy, and enables healthcare organizations to track the utilization and outcomes of their virtual care programs. The company is headquartered in Toronto, Canada.

RaySearch Laboratories enters into interoperability agreement with Varian Medical Systems

RaySearch Laboratories enters into interoperability agreement with Varian Medical Systems

RaySearch Laboratories AB (publ) and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare®* oncology information system to connect to Varian TrueBeam linear accelerators.

The ability to schedule radiation treatments and keep track of the treatment progress is a key functionality in an oncology information system. Under the announced agreement, a dedicated interface has been defined which allows RayCare and Varian TrueBeam to communicate the data necessary for an integrated workflow. This means that clinics will be able to use RayCare to manage all clinical activities around their Varian TrueBeam accelerators.

The development of the interface is already ongoing, and the target is to release it before the end of 2020. Commercial availability will be subject to regulatory clearance in some markets.

Johan Löf, founder and CEO at RaySearch, says: “We are constantly working to add support for more treatment machines in RayCare, and I’m very happy that we have now entered into this agreement. Interoperability with Varian TrueBeam will significantly expand the market potential for RayCare and improve the workflow for our existing customers.”

About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare. Over 2,600 clinics in more than 65 countries use RaySearch software to improve lives and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

About RayCare
RayCare is designed to support the complex logistical challenges of modern oncology clinics. It represents the future of oncology information system technology, supporting the vision of one oncology workflow. Many cancer patients receive a combination of treatment types, and RayCare is designed to reflect that. It will efficiently coordinate activities in radiation therapy, chemotherapy and surgery and will offer advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. RayCare is being developed with tomorrow’s requirements for advanced analytics and decision support in mind.

Molina Healthcare Wins Kentucky Medicaid Contract

Molina Healthcare Wins Kentucky Medicaid Contract

Molina Healthcare, Inc. announced that its Kentucky health plan subsidiary has been selected as an awardee pursuant to the statewide Medicaid managed care RFP issued on January 10, 2020 by the Kentucky Cabinet for Health and Family Services (CHFS), Department for Medicaid Services (DMS).

The new contract for Molina’s Kentucky health plan is expected to begin on January 1, 2021. Molina’s Kentucky health plan is one of five managed care organizations selected to offer health care coverage to approximately 1.4 million Medicaid beneficiaries through the Commonwealth of Kentucky’s TANF, CHIP, and ABD programs.

“We are honored that Kentucky CHFS has selected Molina to serve the Commonwealth’s most vulnerable citizens,” said Joe Zubretsky, Molina’s president and CEO. “We bring to the Commonwealth our Company’s mission of improving the health and well-being of all of our members, and look forward to working with the Beshear Administration, CHFS, and DMS to fulfill that commitment for Kentucky’s Medicaid recipients.”

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 3.4 million members as of March 31, 2020.

1...607608609...1,125Page 608 of 1,125

About us

Hospital & healthcare Management is a leading B2B arena designed for the healthcare sector, it allow members to reach both ends of the healthcare facility procurement chain. . . Read More

Subscribe us

System

Resources

Archive Links

Subscribe

Copyright © 2008 - 2026 Hospital & Healthcare Management. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »